The current status of lymphadenectomy in the management of endometrial cancer

Women's Health

Volumn 7, Issue 1, 2011, Pages 33-35

  Creasman, W T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

endometrial cancer; lymphadenectomy; para aortic; pelvic

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL PRACTICE; ENDOMETRIUM CANCER; FOLLOW UP; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PARAAORTIC LYMPH NODE; PATIENT SELECTION; PELVIS LYMPH NODE; POSTOPERATIVE CARE; PREOPERATIVE CARE; RISK FACTOR; SALPINGOOOPHORECTOMY; WOMEN'S HEALTH;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; RADIOTHERAPY, ADJUVANT;

EID: 78650649478     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.10.85     Document Type: Article

References (12)

1. Jarvet CT: The spread of benign and malignant endometrium in the lymphatic system with a note on coexisting vascular involvement. Am. J. Obstet. Gynecol. 64, 780-806 (1952).
2. Creasman WT, Boronow RC, Marrow CP et al.: Adenocarcinoma of the endometrium: its metastatic lymph node potential. Gyn. Oncology 4, 239 (1976).
3. Creasman WT, Morrow CP, Bundy BN et al.: Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(Suppl. 8), 2035-2041 (1987).
4. Kilgore LC, Patridge EE, Alvarez RD et al.: Adenocarcinoma of the endometrium: survival comparison of patients with and without pelvic node sampling. Gynecol. Oncol. 56(1), 29-33 (1995).
5. Chan JK, Cheung MK, Huh WK et al.: Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107(8), 1823-1830 (2006).
6. Todo Y, Kato H, Kaneuchi M et al.: Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375, 1165-1172 (2010).
7. Kitchener H: ASTEC trial. Lancet 373, 125 (2009).
8. Benedetti Panici P, Basile S, Maneschi F et al.: Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J. Natl Cancer Inst. 100, 1707-1714 (2008).
9. Koc S, Ozer S, Turan T et al.: Detailed analysis of endometrial cancer patients who underwent resection of upper and lower para-aortic nodes durning a lymphadenectomy. Abstract 1486, IGCS, Prague (2010).
10. Shan B, Wang H, Ren Y et al.: Isolated para-aortic lymph nodes metastases in patients with endometrial carcinoma undergoing en bloc pelvic lymphyadenectomy. Isolated para-aortic lymph nodes metastases in patients with endometrial carcinoma undergoing en bloc pelvic lymphyadenectomy. Abstract 1491, IGCS, Prague (2010).
11. El-Balat A, Fotopoulou C, Sehouli J et al.: Systematic pelvic and paraaortic lymphadenectomy in endometrial cancer: lymph node metastasis pattern and identification of predictive factors for lymph-node status. Abstract 160, IGCS, Prague (2010).
12. Suzuki Y, Todo Y, Okamoto K et al.: Therapeutic impact of para-aortic lymphadenectomy in patients with high-risk, early stage and advanced stage endometrial carcinoma. IGCS, Prague (2010).